Trademark: 79080769
Word
LUYE PHARMA
Status Date
Friday, November 11, 2022
Registration Number
4130180
Registration Date
Tuesday, April 24, 2012
Filing Date
Tuesday, November 10, 2009
Published for Opposition
Tuesday, February 7, 2012
Cancellation Date
Friday, November 11, 2022
5 Medicines for human purposes and drugs for medical purposes namely, sodium aescinate injections for the treatment of cerebral edema and edema caused by trauma or operations and of venous back flow obstruction diseases, sodium glycididazole injections in the nature of radiosensitizer for the radiotherapy of solid tumors such as head and neck tumor, lung cancer, and esophageal cancer, and reduced glutathione injections for the treatment of alcoholic fatty liver, alcoholic liver fibrosis, alcoholic liver cirrhosis, acute alcoholic hepatitis, poisoning by radiotherapy, drugs and chemicals; medicinal drinks; pharmaceutical preparations, chemico-pharmaceutical preparations, and chemical preparations for pharmaceutical purposes, namely, sodium aescinate tablets for the treatment of venous edema and soft tissue swelling due to various causes, smectite dispersible tablets and smectite powder sachets for the treatment of acute and chronic bacillary diarrhea of adults and children and for the treatment of pains caused by gullet, stomach and duodenum diseases but not used for spasmolysant, and elcatonin injections for the treatment of bone pains caused by osteoporesis, of hypercalaemia, and of scleromalacia; biological preparations for medical purposes; tonics being medicines, namely, largetrifoliolious bugbane rhizome tablets for the treatment of the pre-menopausal, menopausal and post menopausal syndrome of women, used to relieve the symptoms of hot sweating, restlessness, insomnia, flank pain, dizziness, and tinnitus; gelatin for medical purposes, namely, compound sodium aescinate gel used to relieve the swelling caused by inflammation, degenerative diseases, wounds, ridge pains such as spondylalgia, lumbago, rachialgia, sciatica, closed type acute tissue injuries, lesion in the inter-vertebral disks, varicose of veins, and peritonitis and phlebitis, capsaicin gel used to relieve arthritis and/or muscle pains caused by osteoarthritis, rheumatoid arthritis, myelitis, and fibromyalgia pains caused by sprains to joints; capsules for pharmaceutical purposes, namely, pantoprazole pellets capsules for the treatment of duodenal ulcer, gastric ulcer and acute pathological changes of gastric mucosa, reflux esophagitis and Zollinger-Ellison Syndrome
The mark consists of a miscellaneous design on the left, four Chinese characters on the right and the words "LUYE PHARMA" on the top of the Chinese characters.
Color is not claimed as a feature of the mark.
The non-Latin characters in the mark transliterate to LU YE ZHI YAO and this means GREEN LEAF PHARMACEUTICAL in English.
The wording "LUYE" has no meaning in a foreign language.
"PHARMA" AND THE NON-LATIN CHARACTERS IN THE MARK WHICH TRANSLITERATE TO ZHI YAO
Sep 3, 2023
Total Invalidation Processed By The Ib
Jul 27, 2023
Generic Madrid Transaction Sent To Ib
Jul 27, 2023
Generic Madrid Transaction Created
Jul 11, 2023
Total Invalidation Of Reg Ext Protection Created
Nov 11, 2022
Cancelled Section 71
Apr 24, 2021
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Nov 28, 2019
International Registration Renewed
Aug 12, 2019
Notice Of Acceptance Of Sec. 71 - E-Mailed
Aug 12, 2019
Registered-Sec.71 Accepted
Jun 21, 2019
New Representative At Ib Received
Mar 14, 2019
Teas Response To Office Action-Post Reg Received
Jan 18, 2019
Post Registration Action Mailed - Sec.71
Nov 15, 2018
Case Assigned To Post Registration Paralegal
Oct 18, 2018
Teas Section 71 Received
Dec 15, 2016
Change Of Name/Address Rec'd From Ib
Nov 14, 2012
Notification Processed By Ib
Aug 29, 2012
Final Decision Transaction Processed By Ib
Aug 3, 2012
Final Disposition Notice Sent To Ib
Aug 2, 2012
Final Disposition Processed
Jul 24, 2012
Final Disposition Notice Created, To Be Sent To Ib
Apr 24, 2012
Registered-Principal Register
Feb 11, 2012
Notification Processed By Ib
Feb 7, 2012
Published For Opposition
Jan 18, 2012
Notification Of Possible Opposition Sent To Ib
Jan 18, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2012
Notice Of Publication
Jan 4, 2012
Law Office Publication Review Completed
Jan 3, 2012
Approved For Pub - Principal Register
Dec 29, 2011
Teas/Email Correspondence Entered
Dec 29, 2011
Correspondence Received In Law Office
Dec 29, 2011
Teas Response To Office Action Received
Sep 21, 2011
Notification Of Possible Opposition Sent To Ib
Sep 21, 2011
Notification Of Possible Opposition Created, To Be Sent To Ib
Aug 9, 2011
Non-Final Action Mailed
Aug 8, 2011
Non-Final Action Written
Jul 19, 2011
Teas/Email Correspondence Entered
Jul 19, 2011
Correspondence Received In Law Office
Jul 19, 2011
Teas Response To Office Action Received
Apr 26, 2011
Non-Final Action Mailed
Apr 26, 2011
Non-Final Action Written
Mar 31, 2011
Teas/Email Correspondence Entered
Mar 31, 2011
Correspondence Received In Law Office
Mar 7, 2011
Assigned To Lie
Feb 23, 2011
Teas Response To Office Action Received
Oct 7, 2010
Non-Final Action Mailed
Oct 7, 2010
Non-Final Action Written
Sep 17, 2010
Teas/Email Correspondence Entered
Sep 17, 2010
Correspondence Received In Law Office
Sep 17, 2010
Teas Response To Office Action Received
Jun 4, 2010
Refusal Processed By Ib
Apr 27, 2010
Non-Final Action Mailed - Refusal Sent To Ib
Apr 27, 2010
Refusal Processed By Mpu
Apr 27, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Apr 26, 2010
Non-Final Action Written
Apr 23, 2010
Application Filing Receipt Mailed
Apr 19, 2010
Assigned To Examiner
Apr 19, 2010
New Application Office Supplied Data Entered
Apr 16, 2010
Limitation Of Goods/Services From Ib Entered
Apr 15, 2010
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
